Shuttle Pharmaceuticals Holdings (SHPH) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Shuttle Pharmaceuticals Holdings (SHPH) is Moderate Underperform.

The composite score behind that read is -0.42, weighing +0.22 of bullish evidence against -0.46 bearish.

Shuttle Pharmaceuticals Holdings last closed at $4.06, +1.25% on the session.

Against the IVW growth benchmark the position is +0.64% over the forecast window.

The read is built from 11 underlying insights — 1 bullish and 10 bearish.

Agreement across those insights is 91%.

17 graded predictions for SHPH so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Shuttle Pharmaceuticals Holdings in the 7th percentile on return on equity, where 100 is best.

Shuttle Pharmaceuticals Holdings is classified under Health Care / Biotechnology, with a market capitalisation of $19.11M.

StockMap tracks Shuttle Pharmaceuticals Holdings as the 322nd largest of the 365 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 190 Moderate Underperform, 164 Neutral and 11 Strong Underperform.

On that composite Shuttle Pharmaceuticals Holdings ranks 338th of 365 in the group, against a group median of -0.21.